Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Start of Day Message
-
Vivoryon Therapeutics N.V. Reports Q3 2024 Results and Highlights Progress on Varoglutamstat in Kidney Disease
-
Santhera Receives Positive Recommendation from NICE for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
-
Kitron: Agility driving growth and profits in 2025 and beyond
-
Melexis: Launch of share buy-back program
-
New and updated data for Roche's fixed-duration Columvi and Lunsumio at ASH 2024 reinforce their potential to improve outcomes for people with lymphoma
-
Royal Vopak completes share buyback program 2024
-
Himax and Liqxtal Technology Unveil Revolutionary Liquid Crystal Optical Technologies to be Showcased at CES 2025
-
Matador Technologies Inc. (formerly, Scaling Capital 1 Corp.) Announces Completion of Qualifying Transaction
-
Protara Announces Pricing of $100 Million Public Offering
-
In the Face of Mounting Regulatory Oversight, Honda and Guidewire Join Industry Leaders Securing Software Development at the Open Source Security Foundation (OpenSSF)
-
Customers Bancorp, Inc. Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for th
-
TransAlta Declares Dividends
-
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting
-
Nethermind Joins Japan Open Chain as a Validator as part of its APAC expansion
-
Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting
-
MEDIROM Healthcare Technologies Inc. Announces Pricing of Public Offering
-
National Corporate Credit, Led by Denarii Parchman, Launches Comprehensive Business Loan Programs to Support American Entrepreneurs
-
The North West Company Inc. Announces Third Quarter Earnings and a Quarterly Dividend
-
Imperial Metals and Mount Polley Served with Notice of Charges Alleging Violations of the Fisheries Act
-
CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma
-
Keros Therapeutics Presents Clinical Data from its Elritercept Program at the 66th American Society of Hematology Annual Meeting and Exposition
-
Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024
-
Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, Showing High Overall Response Rate (ORR) with Durable Responses and Favora
-
Sirios Resources Announces Closing of a Second Tranche of $849,000 of its Flow-Through Private Placement
-
ThreeD Capital Inc. Announces Unaudited November 30, 2024 Net Asset Value Per Share – $0.77
-
Cassius Ventures Ltd. Announces Arrangements to Address Mailing Delays as a Result of The Canada Post Strike
-
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Friedman Institute Releases Report on " Analysis on Libyan Oil and Gas Supply - Italy's Strategic Role in Mediterranean Energy "
-
Friedman Institute Releases Report on " Analysis on Libyan Oil and Gas Supply - Italy's Strategic Role in Mediterranean Energy "
-
Blue Star Families Applauds the Unveiling of Landmark NDAA to Make Critical Improvement in Lives of Military Families
-
Teekay Group Announces Changes to Boards of Directors
-
Avance Gas Holding Ltd: Successfully completed the eighth VLGC delivery to BW LPG
-
Nurix Therapeutics Presents New Positive Data from Phase 1a/1b Clinical Trial of NX-5948 in Chronic Lymphocytic Leukemia at the 66th American Society of Hematology Annual Meeting
-
Recursion Reports Interim Phase 1 Clinical Data for REC-617 Monotherapy, a Potential Best-in-Class CDK7 Inhibitor, With Encouraging Patient Response and Favorable Tolerability
-
Aramis Group - Declaration of transactions on own shares conducted from Dec 2 to Dec 6, 2024
-
Bitfarms Announces Restatement of Previously Issued Financial Statements
-
Odronextamab ASH Presentations Underscore Impressive Potential in Earlier Lines of Treatment and Additional Types of Lymphoma
-
TScan Therapeutics to Present Updated Data from the Ongoing ALLOHA™ Phase 1 Heme Trial During Oral Session at the 66th American Society of Hematology Annual Meeting and Exposition
-
Aramis Group - Declaration of transactions on own shares conducted from Nov 25 to Nov 29, 2024
-
Streamline Health® To Report Fiscal Third Quarter 2024 Financial Performance
-
Remilia Corporation launches massively anticipated CULT memecoin
-
Millicom (Tigo) share repurchase activity
-
Ashland rings opening bell at NYSE recognizes 100-year anniversary
-
Ashland rings opening bell at NYSE recognizes 100-year anniversary
-
Onex Corporation Announces Exemptive Relief in Substantial Issuer Bid
-
DR. JEAN MINER NAMED GUTHRIE’S FIRST CHIEF ACADEMIC OFFICER
-
Hurricane Helene: The Young Adults Helping Communities Recover
-
Fitch Ratings Upgrades GCC’s Credit Rating to ‘BBB’
-
Serve Robotics Announces Appointment of Lily Sarafan to its Board of Directors
